We believe Reify Health is paving the way to faster, predictable, and more accessible clinical trials. In addition, the need for further diversity within patient populations in clinical trials is more acute than ever, which makes process visibility and control even more important. In a recent interview, Ralph Passarella said, “sponsors have looked at solutions to make clinical research more accessible to patients and possible for more professionals to participate.” Inefficient patient enrollment creates several far-ranging consequences in the research and development lifecycle, leading to patients with life-threatening and extremely rare conditions being forced to wait for potentially life-saving therapeutics for years. Most biopharma sponsors and clinical research sites find patient enrollment to be one of the biggest challenges to running a successful trial. We at ICONIQ Growth are excited to partner with visionaries like Ralph, Michael and their team at Reify Health as they execute on a bold mission. Having seen family members go through clinical trials, Ralph and Michael know firsthand how critical clinical research can be to patients with rare medical conditions seeking hope in the form of experimental treatments. For Ralph and Michael, this challenge is not just another business problem, but one that is deeply personal. The duo started Reify Health in 2012 to accelerate clinical trials and bring life-saving therapies to market faster. The two met at the Johns Hopkins University School of Medicine and instantly connected on the need to bring transparency to an ecosystem that has historically worked in arcane silos. For more information and a complete list of portfolio companies, please visit ICONIQGrowth.When our team at ICONIQ Growth first met Ralph Passarella and Michael Lin, we were immediately struck by their ambitious vision for a very different future of clinical trials - one we believe is radically more accessible, scalable, and efficient. ICONIQ Growth's portfolio of innovators includes Adyen, AirBnB, Alibaba, Alteryx, Automattic, BambooHR, Braze, Chime, Collibra, Coupa, Datadog, Docusign, Gitlab, Marqeta, Miro, Procore, Red Ventures, Relativity, ServiceTitan, Snowflake, Sprinklr, Truckstop, Uber, Wolt, and Zoom, among others. Our unique investment platform harnesses the power of ICONIQ Capital's vibrant ecosystem of founders, pioneers, and business leaders with the goal of delivering tangible value and amplifying our portfolio companies' success from early growth stage to IPO and beyond. We are inspired by visionaries defining the future of their industries by building company cultures that endure. ICONIQ Growth partners with exceptional entrepreneurs and leaders who drive global impact and change. Backed by ICONIQ Growth, Bain Capital Ventures, Accomplice VC, and Glasswing Ventures, Reprise is paving the way for full funnel product-led growth. With Reprise, teams can create immersive, lightweight experiences of the product's key features, enabling customers to reach "wow" moments faster. Reprise is the leading enterprise-ready product experience platform that enables sales and marketing teams to control the narrative of their demo/product experiences without needing engineering involvement. Jayni Shah, Partner at Fifth Down Capital Ryan Peterson, CEO, & Ben Braverman, Chief Customer Officer of Flexport John Nisi, GM and COO of US Cloud at Microsoft Phil Fernandez, co-founder, former Chairman & CEO of Marketo Rahul Vohra, CEO of Superhuman & Todd Goldberg, founder of Eventjoy Lauren Farleigh, Partner at Mischief Capital & Zach Perret, CEO at Plaid "We use Reprise to drive interactive product demonstrations, make those same demonstrations available on Cloudera web properties, and significantly reduce cloud costs-especially for our SE teams."Īdditional investors joining the round are: "Reprise has allowed us to enable teams at every level," said Sam Heywood, VP Product Marketing at Cloudera. Customers like ZoomInfo, Outreach, Silicon Valley Bank, and Cloudera rely on Reprise for their demo and product experiences. Reprise has expanded rapidly since its founding in 2020, with over 900% year-over-year ARR growth and 700% year-over-year team growth. This funding will accelerate getting our product into the hands of customers that need it." "Sales and marketing teams need to use their product to spur growth, but relying on engineering teams and slow demo environments kills their momentum. "We've seen an unprecedented industry need for platforms like Reprise," added Bryan Stevenson, co-founder and co-CEO of Reprise.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |